Search

everythinglearnresearchcommunity

for

Search:↓

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Finasteride caused enlarged breast tissue in a 62-year-old man.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

Androgen use may increase the risk of stroke, but more research is needed.

Secondary amenorrhea has many causes and requires thorough evaluation to treat and restore menstrual cycles.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.